Quarterly report pursuant to Section 13 or 15(d)

3. Summary of Significant Accounting Policies (Tables)

v3.20.4
3. Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Computation of earnings per share

Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable.

 

    Three Months Ended December 31,     Nine Months Ended December 31,  
(In thousands, except per share data)   2020     2019     2020     2019  
Numerator:                                
Loss from continuing operations   $ (626 )   $ (1,210 )   $ (1,183 )   $ (1,824 )
Income (loss) from discontinued operations     (24 )     126       893       252  
Net loss   $ (650 )   $ (1,084 )   $ (290 )   $ (1,572 )
                                 
Denominator:                                
Weighted-average number of common shares outstanding: basic and diluted     2,052       1,500       1,967       1,378  
                                 
Loss per share from continuing operations   $ (0.31 )   $ (0.81 )   $ (0.60 )   $ (1.32 )
Income (loss) per share from discontinued operations     (0.01 )     0.09       0.45       0.18  
Net loss per share: basic and diluted   $ (0.32 )   $ (0.72 )   $ (0.15 )   $ (1.14 )
Schedule of antidilutive shares

The computation of basic loss per share for the three and nine months ended December 31, 2020 and 2019 excludes the potentially dilutive securities summarized in the table below because their inclusion would be anti-dilutive.

 

    Three Months Ended December 31,     Nine Months Ended December 31,  
(In thousands)   2020     2019     2020     2019  
Stock options     61       358       70       358  
Restricted stock     1       2       1       2  
Series C     –       17       –       17  
Warrants     119       468       119       468  
Common stock units (1)     46       46       46       46  
      227       891       236       891  

 

(1) Consists of 30,668 restricted stock units and warrants to purchase 15,332 shares of common stock
Disaggregated Revenue by Source

The following table presents the Company’s disaggregated revenues by revenue source:

 

(In thousands)   Three Months Ended December 31,     Nine Months Ended December 31,  
Product   2020     2019     2020     2019  
Human Care   $ 3,534     $ 3,528     $ 13,628     $ 11,290  
Animal Care     1,357       853       2,745       2,188  
Other     45       14       99       138  
    $ 4,936     $ 4,395     $ 16,472     $ 13,616